Skip to main content
Fig. 2 | Stem Cell Research & Therapy

Fig. 2

From: Harvesting multipotent progenitor cells from a small sample of tonsillar biopsy for clinical applications

Fig. 2

Characterization of T-MPCs by immunostaing and flow cytometry. a Analysis of costaining demonstrates that our T-MPCs are CD44 and CD90, CD73, and CD105 positive and CD19 and HLA-DR negative. n = 14 donors in triplicates. Bm-MPC bone marrow-derived mesenchymal progenitor cell, T-MPC tonsillar mesenchymal progenitor cells. b A fraction of our T-MPCs express the pluripotency related markers SSEA4, c TRA-1-80 and d TRA-1-60

Back to article page